Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Company profile
Ticker
APEN
Exchange
Website
CEO
Gary Atkinson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
JCG INC, LPATH INC, LPATH, INC, NEIGHBORHOOD CONNECTIONS INC
SEC CIK
Corporate docs
IRS number
161630142
APEN stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
14 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
EFFECT
Notice of effectiveness
10 Apr 23
Transcripts
APEN
Earnings call transcript
2022 Q3
2 Nov 22
APEN
Earnings call transcript
2022 Q2
8 Aug 22
APEN
Earnings call transcript
2022 Q1
4 May 22
APEN
Earnings call transcript
2021 Q4
23 Feb 22
APEN
Earnings call transcript
2021 Q3
2 Nov 21
APEN
Earnings call transcript
2021 Q2
4 Aug 21
APEN
Earnings call transcript
2021 Q1
4 May 21
APEN
Earnings call transcript
2020 Q4
27 Feb 21
APEN
Earnings call transcript
2020 Q2
5 Aug 20
APEN
Earnings call transcript
2020 Q1
4 May 20
Latest ownership filings
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 58.01 mm | 58.01 mm | 58.01 mm | 58.01 mm | 58.01 mm | 58.01 mm |
Cash burn (monthly) | 3.30 mm | 2.82 mm | 3.77 mm | 3.43 mm | 3.43 mm | 2.61 mm |
Cash used (since last report) | 52.05 mm | 44.41 mm | 59.43 mm | 54.12 mm | 54.15 mm | 41.08 mm |
Cash remaining | 5.96 mm | 13.60 mm | -1.41 mm | 3.89 mm | 3.86 mm | 16.93 mm |
Runway (months of cash) | 1.8 | 4.8 | -0.4 | 1.1 | 1.1 | 6.5 |
Institutional ownership, Q1 2023
78.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 91 |
Opened positions | 29 |
Closed positions | 24 |
Increased positions | 32 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 403.08 bn |
Total shares | 45.28 mm |
Total puts | 15.00 k |
Total calls | 2.12 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
CPMG | 6.18 mm | $61.34 bn |
Nantahala Capital Management | 4.58 mm | $45.38 bn |
Highland Capital Management Fund Advisors | 3.61 mm | $35.85 bn |
Hedgehog Capital | 2.82 mm | $27.95 mm |
C Citigroup | 2.00 mm | $19.84 bn |
Woodline Partners | 1.81 mm | $17.95 bn |
Vanguard | 1.79 mm | $17.80 bn |
Schonfeld Strategic Advisors | 1.74 mm | $17.26 bn |
Gardner Lewis Asset Management L P | 1.43 mm | $14.17 bn |
Ergoteles | 1.41 mm | $14.03 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Apr 23 | Pacitti David | Common Stock | Sale back to company | Dispose D | No | No | 0 | 18,112 | 0.00 | 0 |
4 Apr 23 | Pacitti David | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.95 | 19,333 | 76.37 k | 0 |
4 Apr 23 | Pacitti David | NQSO Common Stock | Sale back to company | Dispose D | No | No | 8.86 | 5,271 | 46.70 k | 0 |
4 Apr 23 | Pacitti David | NQSO Common Stock | Sale back to company | Dispose D | No | No | 2.08 | 27,749 | 57.72 k | 0 |
4 Apr 23 | Pacitti David | NQSO Common Stock | Sale back to company | Dispose D | No | No | 3.27 | 16,536 | 54.07 k | 0 |
4 Apr 23 | Pacitti David | Stock Option Common Sock | Sale back to company | Dispose D | No | No | 3.98 | 15,154 | 60.31 k | 0 |
4 Apr 23 | Mike Gutteridge | Common Stock | Sale back to company | Dispose D | No | No | 0 | 86,647 | 0.00 | 0 |
4 Apr 23 | Mike Gutteridge | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.63 | 11,611 | 65.37 k | 0 |
4 Apr 23 | Mike Gutteridge | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.95 | 14,846 | 88.33 k | 0 |
4 Apr 23 | Mike Gutteridge | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.08 | 22,171 | 46.12 k | 0 |